lystn

This  week,  I  welcome  Dr.  Jeff  Stanley  of  Virta  Health  back  to  the  podcast  to  discuss the  results  from  their  one-year  Cardiovascular  Risk  Factor  Assessment  clinical  trial.  The  results, which  are  published  in  the  peer-reviewed  publication  Cardiovascular  Diabetology,  include  some very  impressive  findings.  Findings that may just shake up conventional wisdom about a high fat diet. During  our  conversation,  we  discuss  the  details of the trial, and also explore practical implications of a ketogenic diet, intermittent  fasting,  macro  calculations,  and  beta-hydroxybutyrate  measurements. Dr Stanley and Virta health have already revolutionized the way we treat diabetes, and this latest trial only furthers that mission.   Key Takeaways:   [4:31] Virta Health's method is to safely and sustainably reverse type 2 diabetes. [9:08] New data will soon be published by Virta. [13:42] The guidelines and macro data Virta uses with patients. [19:25] Advice for people seeking information on a ketogenic diet from their doctor. [22:15] Obstacles patients face with staying compliant to treatment and lifestyle changes. [26:12] Virta’s priority when discussing intermittent fasting is safety, safety, safety. [30:26] What does the cardiovascular intervention trial data show after one year? [51:55] What pushback is Virta experiencing after publishing their results?   Mentioned in This Episode: Low Carb Cardiologist Website Dr. Scher on Twitter Dr. Scher on Facebook Virta Health Low Carb Cardiologist Podcast with Dr. Jeff Stanley Episode #11 Low Carb Cardiologist Podcast with Dr. Victor Montori Episode #30   This Episode is Sponsored by:   Oura Ring Sleep Tracking Technology helps improve your understanding of the depth, quality, and length of your sleep. Visit OuraRing.com and at checkout use the code ‘LOWCARBCARDIOLOGIST’ to get $50 off your order.